Hemogenyx Pharmaceuticals Plc
HOPHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$5,625 | -$6,696 | -$3,987 | -$5,108 |
| Dep. & Amort. | $639 | $646 | $195 | $126 |
| Deferred Tax | $0 | $0 | $4 | -$18 |
| Stock-Based Comp. | $344 | $243 | $18 | $153 |
| Change in WC | $256 | -$834 | $243 | $101 |
| Other Non-Cash | $246 | $536 | $617 | $2,118 |
| Operating Cash Flow | -$4,140 | -$6,106 | -$2,911 | -$2,627 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$13 | -$117 | -$429 | -$818 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$2 | -$139 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $12 | $85 | $11 | $18 |
| Investing Cash Flow | -$2 | -$32 | -$420 | -$939 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$635 | $0 | $0 | $8,817 |
| Stock Issued | $4,645 | $5,088 | $0 | $12,000 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$932 | -$639 | -$110 | -$39 |
| Financing Cash Flow | $3,077 | $4,449 | -$110 | $8,778 |
| Forex Effect | -$24 | $403 | -$876 | -$183 |
| Net Chg. in Cash | -$1,088 | -$1,285 | -$4,308 | $5,029 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,248 | $2,533 | $6,841 | $1,812 |
| End Cash | $159 | $1,248 | $2,533 | $6,841 |
| Free Cash Flow | -$4,153 | -$6,223 | -$3,340 | -$3,445 |